CTKB Cytek Biosciences: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Cytek Biosciences - graphic logo of issuer CTKB

The EV/EBITDA chart demonstrates steady growth in demand for high-precision cellular analytics from the scientific and pharmaceutical sectors. Cytek Biosciences, Inc. (CTKB) develops spectral cytometry systems for the B2B segment, enabling the deep study of cellular parameters. Revenue is generated through the sale of innovative equipment to medical centers and laboratories. The current value of this metric is 0.00, which helps investors determine the fundamental floor of the business.

Cytek Bio - CTKB Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/10/2026)

Summary analytical data breakdowns for cytekbio.com (CTKB)

- stock price and consensus target price:
Stock Quotes Cytek Bio|CTKB - Average Forecast Price
- company stock capitalization data:
Market Value Cytek Corp|CTKB - Company Buyout Price
- book value of equity indicators:
Book Value per Share Cytek Biosciences|CTKB - Book Valuation of Business|Market Value to Book Value Ratio cytekbio.com|CTKB - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Cytek Biosciences, Inc.|CTKB - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Cytek Biosciences|CTKB - Company Cumulative Debt|Debt to Book Value Cytek Corp|CTKB - Amount of Long-Term Liabilities|Company Short-Term Debts Cytek Biosciences|Quick Liquidity cytekbio.com
- financial results and valuation multiples details:
CTKB - Net Profit|Future Profit Cytek Biosciences, Inc.|CTKB - Company Value to Net Income|Forward P/E Multiple Cytek Biosciences, Inc.|CTKB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Cytek Corp|CTKB - Operating income before deduction of amortization|Earnings per share for the last twelve months Cytek Biosciences|CTKB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cytekbio.com|CTKB - Expected net earnings per share growth this year|Earnings growth forecast for next year Cytek Biosciences, Inc.
Initial company analysis:Cytek Bio (CTKB)
Product sample of Cytek Biosciences Inc

This indicator compares the total enterprise value, including debt, with earnings before interest, taxes, depreciation, and amortization, providing a real-time assessment of cash flow generation efficiency. While it serves as a fundamental benchmark for identifying undervalued assets, the EV/EBITDA trend for Cytek Biosciences, Inc. (CTKB) depends critically on the company's ability to maintain its technological leadership in cytometry amidst the expansion of low-cost startup platforms.

Competing companies

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Enterprise Value to EBITDA Ratio opko.com OPK|CareDx Inc - Enterprise Value to EBITDA Ratio|Maravai LifeSciences Holdings (MRVI) - Company Value to EBITDA|FLGT: Enterprise Value to EBITDA Ratio|Standard BioTools Corp - Enterprise Value to Operating Income Before Depreciation Ratio|OSUR: EV/EBITDA Multiple|Company Value to EBITDA Exagen (XGN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MDxHealth|EV/EBITDA Multiple Lucid Diagnostics, Inc.|Enterprise Value to EBITDA Ratio PRE (Prenetics Global)|IMDX (imdxinc.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple TRIB (Trinity Biotech)|prophaselabs.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Ainos - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Co-Diagnostics Inc CODX|Heart Test Laboratories Inc. (HSCS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Biomerica Inc (BMRA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|onconetix.gcs-web.com (ONCO) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple VRAX|Enterprise Value to EBITDA Ratio Bluejay Diagnostics Inc BJDX|EV/EBITDA Multiple AWH (Vermillion)|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc (AXDX)|CENTOGENE, N.V. - EV/EBITDA Multiple|Company Value to EBITDA Enzo Biochem, Inc.|fresh2.co (FRES) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation GENE|ME (23andMe Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Psychemedics Inc (PMD)